Cargando…
Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging
Cutaneous melanoma (CM) survival is assessed using averaged data from the American Joint Committee on Cancer 8th edition (AJCC8). However, subsets of AJCC8 stages I–III have better or worse survival than the predicted average value. The objective of this study was to determine if the 31-gene express...
Autores principales: | Wisco, Oliver J., Marson, Justin W., Litchman, Graham H., Brownstone, Nicholas, Covington, Kyle R., Martin, Brian J., Quick, Ann P., Siegel, Jennifer J., Caruso, Hillary G., Cook, Robert W., Winkelmann, Richard R., Rigel, Darrell S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893124/ https://www.ncbi.nlm.nih.gov/pubmed/35254332 http://dx.doi.org/10.1097/CMR.0000000000000804 |
Ejemplares similares
-
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group
por: Farberg, Aaron S., et al.
Publicado: (2022) -
The continuing impact of COVID-19 on dermatology practice: Office workflow, economics, and future implications
por: Litchman, Graham H., et al.
Publicado: (2021) -
Long-Term Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma
por: Hsueh, Eddy C., et al.
Publicado: (2021) -
The immediate impact of COVID-19 on US dermatology practices
por: Litchman, Graham H., et al.
Publicado: (2020) -
Performance of a 31‐gene expression profile test in cutaneous melanomas of the head and neck
por: Gastman, Brian R., et al.
Publicado: (2019)